Abstract

BackgroundBacterial pathogen (Pseudomonas aeruginosa) could form biofilm that conveys multi-drug resistance. Bacteriophage as an alternative to antibacterial resistance is useful against biofilm complications. This study evaluated antibacterial and biofilm removal activities of lytic phage, specific against multi-drug-resistant clinical P. aeruginosa.ResultsThe phage showed a wide range of pH (5–10) and heat (7–44 °C) stability. Electron microscopy showed ɸPauNE1 phage head (60 nm in diameter) and non-contractile tail (12 nm in length by 8 nm in width); hence, the family Podoviridae and the order Caudovirales. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) showed structured protein of 55 kDa and double-stranded DNA of 45 kb. The phage was species specific and had broad host range activity. It inhibited bacterial growth at multiplicity of infection (MOI) 1–0.000001 pfu/ml. Inhibition was maximal at both low (1 × 105) and high (1 × 109) bacterial CFU/ml. Biofilm removal test showed that the phage removed more than 60% cell biomass within CFU/ml of 1.5 × 108, 6.0 × 108 and l.0 × 109.ConclusionPhage (ɸPauNE1) was unique and had broad host range activity. The phage exhibited strong bacteriolytic activity against biofilm forming multi-drug-resistant strains. It had no lytic effect on the heterogeneous strains and so a promising bioagent.

Highlights

  • Bacterial pathogen (Pseudomonas aeruginosa) could form biofilm that conveys multi-drug resistance

  • Pseudomonas aeruginosa is a pathogen frequently implicated in healthcare-associated infections (HAIs), especially in critically ill and patients with low immunity [1]

  • It was further identified with VITEK®-2 automated system using Gram negative identification (GN ID) card according to the manufacturer’s instruction (BioMerieux, France) [16]

Read more

Summary

Introduction

Bacterial pathogen (Pseudomonas aeruginosa) could form biofilm that conveys multi-drug resistance. Pseudomonas aeruginosa is a pathogen frequently implicated in healthcare-associated infections (HAIs), especially in critically ill and patients with low immunity [1]. It is a versatile pathogen with the ability to cause diverse range of infections such as superficial infections, systemic and life-threatening conditions with mortality rate of 40–60% [2]. Available clinical data suggest that high morbidity and mortality rates associated with antibacterialresistant P. aeruginosa infections are mainly nosocomial and in particular surgical wounds [1]. Patients with this complication have prolonged hospital stay [1]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call